Someone said:
"...it makes perfect sense. If your pharma, and you want to own the industry, and you have FDA in your pocket, it makes every sense in the world."
No. If you're pharma you want cannabis to be restricted and research be limited as much as possible.
280E bleed legal companies dry, even MSOs (hence their stock pump at the news of it even being suggested to be removed.. Meanwhile the top cannabis patent holding pharma cos. stocks declined.. must be a ruse by pharma? lol)
Research restrictions do not limit pharma, they limit universities and smaller operators.
Pharma can and has gone overseas for research and cultivation, but they can synthesize cannabinoids here anyways....
I think people who believe Schedule III gives pharma an advantage have a fundamental misunderstanding of how the CSA, FDA, and DEA works.
Here's a resource I invite people to read with an open mind and a mindset to refute facts and points, not sources. Otherwise, you are STILL operating from emotion, not facts or reality.
The debate is not about if Schedule III is good, it is about what it WOULD mean and what it would NOT mean -- if accepted by the DEA.
This alone seems to go over many people's heads. Again, emotional response - versus reality based.
Critical Rationalist | Water | Climate | Finance
3wThe most used drug surely must be alcohol, followed by nicotine.